FHIR IG analytics| Package | hl7.fhir.uv.xver-r2.r4b |
| Resource Type | ValueSet |
| Id | ValueSet-R2-v3-substanceAdminSubstitution-for-R4B.json |
| FHIR Version | R4B |
| Source | http://hl7.org/fhir/uv/xver-r2.r4b/0.1.0/ValueSet-R2-v3-substanceAdminSubstitution-for-R4B.html |
| URL | http://hl7.org/fhir/uv/xver/ValueSet/R2-v3-substanceAdminSubstitution-for-R4B |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-03-17T21:02:03.8104715+00:00 |
| Name | R2V3SubstanceAdminSubstitutionForR4B |
| Title | Cross-version ValueSet DSTU2.v3 Code System substanceAdminSubstitution for use in FHIR R4B |
| Realm | uv |
| Authority | hl7 |
| Description | This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` for use in FHIR R4B. |
| Purpose | This value set is part of the cross-version definitions generated to enable use of the value set `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` as defined in FHIR DSTU2 in FHIR R4B. The source value set is bound to the following FHIR DSTU2 elements: * Across FHIR versions, the value set has been mapped as: * `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` * `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2016-11-11` * `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution|2018-08-12` Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (9). All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (9). FHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31`, defined in FHIR DSTU2 does not have any mapping to FHIR R4B |
No resources found
| CodeSystem | ||
| hl7.fhir.uv.xver-r2.r4b#0.1.0 | substanceAdminSubstitution | v3-substanceAdminSubstitution |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet R2-v3-substanceAdminSubstitution-for-R4B
This value set expansion contains 10 concepts.
| System | Version | Code | Display | Definition |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | BC | brand composition | Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | E | equivalent | Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product. |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | EC | equivalent composition | Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | F | formulary | Description: This substitution was performed or is permitted based on formulary guidelines. |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | G | generic composition | Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp) |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | N | none | No substitution occurred or is permitted. |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | TB | therapeutic brand | Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | TE | therapeutic alternative | Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | TG | therapeutic generic | Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine |
http://hl7.org/fhir/v3/substanceAdminSubstitution | 1.0.2 | _ActSubstanceAdminSubstitutionCode | ActSubstanceAdminSubstitutionCode | Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects. |
FHIR
FHIRsmith{
"resourceType": "ValueSet",
"id": "R2-v3-substanceAdminSubstitution-for-R4B",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "fhir"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r2.r4b"
},
{
"url": "version",
"valueString": "0.1.0"
},
{
"url": "uri",
"valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 0,
"_valueInteger": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/xver/ValueSet/R2-v3-substanceAdminSubstitution-for-R4B",
"version": "0.1.0",
"name": "R2V3SubstanceAdminSubstitutionForR4B",
"title": "Cross-version ValueSet DSTU2.v3 Code System substanceAdminSubstitution for use in FHIR R4B",
"status": "active",
"experimental": false,
"date": "2026-03-17T21:02:03.8104715+00:00",
"publisher": "FHIR Infrastructure",
"contact": [
{
"name": "FHIR Infrastructure",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/fiwg"
}
]
}
],
"description": "This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` for use in FHIR R4B.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` as defined in FHIR DSTU2\r\nin FHIR R4B.\r\n\r\nThe source value set is bound to the following FHIR DSTU2 elements:\r\n* \r\n\r\nAcross FHIR versions, the value set has been mapped as:\r\n* `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31`\n* `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2016-11-11`\n* `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution|2018-08-12`\r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\nAll concepts in the comparison are listed as identical.\nThe source and target value sets have the same number of active concepts (9).\nAll concepts in the comparison are listed as identical.\nThe source and target value sets have the same number of active concepts (9).\nFHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31`, defined in FHIR DSTU2 does not have any mapping to FHIR R4B",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"concept": [
{
"code": "BC",
"display": "brand composition"
},
{
"code": "E",
"display": "equivalent"
},
{
"code": "EC",
"display": "equivalent composition"
},
{
"code": "F",
"display": "formulary"
},
{
"code": "G",
"display": "generic composition"
},
{
"code": "N",
"display": "none"
},
{
"code": "TB",
"display": "therapeutic brand"
},
{
"code": "TE",
"display": "therapeutic alternative"
},
{
"code": "TG",
"display": "therapeutic generic"
},
{
"code": "_ActSubstanceAdminSubstitutionCode",
"display": "ActSubstanceAdminSubstitutionCode"
}
]
}
]
},
"expansion": {
"timestamp": "2026-03-17T21:02:03.8104715+00:00",
"contains": [
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "BC",
"display": "brand composition"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "E",
"display": "equivalent"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "EC",
"display": "equivalent composition"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "F",
"display": "formulary"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "G",
"display": "generic composition"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "N",
"display": "none"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "TB",
"display": "therapeutic brand"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "TE",
"display": "therapeutic alternative"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "TG",
"display": "therapeutic generic"
},
{
"system": "http://hl7.org/fhir/v3/substanceAdminSubstitution",
"version": "1.0.2",
"code": "_ActSubstanceAdminSubstitutionCode",
"display": "ActSubstanceAdminSubstitutionCode"
}
]
}
}